Novartis - Crunchbase Company Profile & Funding

Q: Where is Novartis's headquarters?

Novartis is located in Basel, Basel-Stadt, Switzerland.

Q: Who invested in Novartis?

Novartis is funded by Bill & Melinda Gates Foundation.

Q: When was the last funding round for Novartis?

Novartis closed its last funding round on obfuscated from a Post-IPO Debt round.

Q: How much funding has Novartis raised to date?

Novartis has raised obfuscated.

Overview

Novartis

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+3 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Novartis

CB Rank

1657

Novartis is a pharmaceutical company that researches and develops medicines for serious diseases to improve and extend people's lives.

Founded

obfuscation

Public

Post-IPO Debt

Basel, Basel-Stadt, Switzerland

10001+

www.novartis.com

Biotechnology

Health Care

Medical

Pharmaceutical

Precision Medicine

Funding Rounds

Post-IPO Debt

OBF

obfuscation

Post-IPO Debt

OBF

obfuscation

Grant

OBF

obfuscation

Key People

Peggy Carter: Director Regulatory Affairs
Past Role: Ventana Medical Systems, Senior Manager, Regulatory Affairs
Michelle Chernock: Therapeutic Area Head for Neuroscience
Past Role: Santen, Head of Global Medical Affairs

Details

Sub-Organization of

Meye Asset Management

Legal Name

Novartis AG

Also Known As

Novartis Group, Novartis AG

Operating Status

Active

Number of Exits

obfuscation

Stock Symbol

NYSE:NVS

Founders

Alexander Clavel, Joerg Reinhardt, Johann Rudolf, Shwen Gwee

About the Company

Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

Investor Type

obfuscation

Predictions & Insights

Growth Insight

See this Growth Insight

Novartis is

Lorem

to be growing

Top Contributing Factors

Financial Growth

Products & Services

Fabhalta®

A medication for patients with paroxysmal nocturnal hemoglobinuria (PNH) that improves hemoglobin levels.

Pluvicto™

A treatment for PSMA-positive metastatic hormone-sensitive prostate cancer that improves radiographic progression-free survival.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Debt - Novartis	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Novartis	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Novartis	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Novartis	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Novartis	—	obfuscated obfuscation	—	Post-IPO Debt

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Debt - Novartis	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Novartis	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Novartis	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Novartis	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Novartis	—	obfuscated obfuscation	—	Post-IPO Debt

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Bill & Melinda Gates Foundation	Yes	Grant - Novartis	—
Bill & Melinda Gates Foundation	Yes	Grant - Novartis	—
Bill & Melinda Gates Foundation	Yes	Grant - Novartis	—
Bill & Melinda Gates Foundation	Yes	Grant - Novartis	—
Bill & Melinda Gates Foundation	Yes	Grant - Novartis	—

Investments

Investment Breakdown

Diversity Investments

Number of Investments

Number of Exits

obfuscation

Number of Acquisitions

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Relation Therapeutics	Yes	Venture Round - Relation Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Relation Therapeutics	Yes	Venture Round - Relation Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Relation Therapeutics	Yes	Venture Round - Relation Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Relation Therapeutics	Yes	Venture Round - Relation Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Relation Therapeutics	Yes	Venture Round - Relation Therapeutics	obfuscated obfuscation

Investment Breakdown

Number of Investments

Number of Exits

obfuscation

Number of Acquisitions

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Relation Therapeutics	Yes	Venture Round - Relation Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Relation Therapeutics	Yes	Venture Round - Relation Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Relation Therapeutics	Yes	Venture Round - Relation Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Relation Therapeutics	Yes	Venture Round - Relation Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Relation Therapeutics	Yes	Venture Round - Relation Therapeutics	obfuscated obfuscation

Diversity Investments

Number of Diversity Investments

Announced Date	Organization Name	Diversity Spotlight	Funding Round	Money Raised
obfuscated obfuscation	Octave	Women Founded	Series C - Octave	obfuscated obfuscation
obfuscated obfuscation	Octave	Women Founded	Series B - Octave	obfuscated obfuscation
obfuscated obfuscation	RxLightning	Women Founded, Women Led	Series A - RxLightning	obfuscated obfuscation
obfuscated obfuscation	Patientory	Black Founded, Black Led, Women Founded, Women Led	Seed Round - Patientory	obfuscated obfuscation
obfuscated obfuscation	Alladapt Immunotherapeutics	Women Founded, Women Led	Venture Round - Alladapt Immunotherapeutics	obfuscated obfuscation
obfuscated obfuscation	Lightship	Women Founded	Series B - Lightship	obfuscated obfuscation
obfuscated obfuscation	Science 37	Women Founded	Venture Round - Science 37	obfuscated obfuscation
obfuscated obfuscation	Ayala Pharmaceuticals	Women Founded, Women Led	Series B - Ayala Pharmaceuticals	obfuscated obfuscation
obfuscated obfuscation	Semma Therapeutics	Women Founded	Series B - Semma Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Homology Medicines	Women Founded	Series B - Homology Medicines	obfuscated obfuscation